GlaxoSmithKline Pharmas Q3 net profit down 33%
The company reported net profit of Rs 52.95 crore, a drop of 32.91% from Rs 78.93 crore in the corresponding period of the previous year.
GlaxoSmithKline Pharmaceuticals on Saturday stated that its net profit for the third quarter ended December 31, 2016, period had declined by 33% on year-on-year (YoY) basis.
The company reported net profit of Rs 52.95 crore, a drop of 32.91% from Rs 78.93 crore in the corresponding period of the previous year.
Compared with Rs 98.85 crore of preceding quarter, the net profit declined by 46.43%.
Total income from operations stood at Rs 706.38 crore, decreasing by 5.90% year-on-year (YoY) and 11.60% quarter-on-quarter (QoQ).
Operating profit (EBITDA) was at Rs 45.50 crore, down by 54.62% from Rs 100.27 crore a year ago same period.
On Friday, the shares of GlaxoSmithKline Pharma closed at Rs 2741.05 per piece on BSE, above Rs 8 or 0.32%.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.